The British Journal of Psychiatry · 2008 · 149 citations · 16 references
Public HealthMaternal HealthObstetricsInfant HealthMaternal-fetal MedicinePsychopharmacologyBirth Outcomes EpidemiologyLow Birth Weight EpidemiologyPerinatal Risk FactorsPrenatal DevelopmentPrenatal ToxicityPrenatal ToxicologyBirth Weight AssessmentMaternal Exposure EffectsNeurodevelopmental Outcomes After Prenatal ExposurePerinatal Drug ExposurePharmaceutical Exposure During PregnancyPregnancy Drug ExposurePrenatal Drug ExposureProspective Cohort Data
BACKGROUND: The effects of in utero exposure to atypical antipsychotics on infant birth weight are unknown. AIMS: To determine whether atypical and typical antipsychotics differ in their effects on birth weight after maternal exposure during pregnancy. METHOD: Prospective data on gestational age and birth weight collected by the National Teratology Information Service for infants exposed to typical (n=45) and atypical (n=25) antipsychotics was compared with data for a reference group of infants (n=38). RESULTS: Infants exposed to atypical antipsychotics had a significantly higher incidence of large for gestational age (LGA) than both comparison groups and a mean birth weight significantly heavier than those exposed to typical antipsychotics. In contrast those exposed to typical antipsychotics had a significantly lower mean birth weight and a higher incidence of small for gestational age infants than the reference group. CONCLUSIONS: In utero exposure to atypical antipsychotic drugs may increase infant birth weight and risk of LGA.
16
Macrosomia--maternal characteristics and infant complications.
William N. Spellacy, Suellen Miller, Ann Winegar et al. · PubMed · 1985 · 407 citations
Fetal and Neonatal Outcomes of Diabetic Pregnancies
Joanne Yang, Elizabeth Cummings, Colleen O’Connell et al. · Obstetrics and Gynecology · 2006 · 356 citations